Treatment of lung cancer cells with artocarpin at non-toxic concentrations significantly reduced the expression levels of EMT markers, such as N-cadherin, Vimentin, and Slug, while increasing E-cadherin (Figure 5), indicating the effect of artocarpin in terms of its inhibition of EMT. This evidence concerns the gene CDH1 and lung carcinoma.